Stocks

INVO Bioscience Reports Decreased Quarterly Loss; Shares Soar by Over 31% in Premarket

Published November 14, 2023

In a significant premarket surge, shares of INVO Bioscience, Inc. INVO climbed more than 31% following the announcement of the company's third-quarter financial results. INVO Bioscience achieved a substantial reduction in its quarterly loss, reporting a loss of 70 cents per share compared to the loss of $4.19 per share from the same period last year. In tandem, the company's quarterly sales witnessed a dramatic 314% rise year-over-year, totaling $974,894.

Broader Market Movements

Apart from INVO, several other stocks also made notable moves in the premarket trading session. Noteworthy mentions include Fisker Inc. FSR, known for their focus on the electric vehicle market; Hanryu Holdings, Inc. HRYU, the operator of the global social media platform FANTOO; TRACON Pharmaceuticals, Inc. TCON, a developer of cancer and age-related disease therapies; Advent Technologies Holdings, Inc. ADN, specializing in hydrogen and fuel cell technology; RedHill Biopharma Ltd. RDHL, focusing on gastrointestinal and infectious diseases; and Harrow Health, Inc. HROW, an ophthalmology-focused healthcare company.

In the realm of biopharmaceuticals and biotech, Alaunos Therapeutics, Inc. TCRT focuses on immuno-oncology therapies, while Applied UV, Inc. AUVI designs disinfectant systems for healthcare facilities. PaxMedica Inc. PXMD aims at developing treatments for neurodevelopmental disorders, and Beyond Air, Inc. XAIR innovates in nitric oxide-based therapies.

Other stocks that gathered attention include Peraso, Inc. PRSO, a developer of 5G silicon devices; Edge Systems, LLC SKIN, which operates in the aesthetic technology market; Tenax Therapeutics, Inc. TENX, focusing on cardiovascular and pulmonary diseases; Singular Genomics Systems, Inc. OMIC, advancing sequencing technology; and Theseus Pharmaceuticals, Inc. THRX, dedicated to targeted cancer therapies.

INVO, premarket, shares, earnings, biopharmaceuticals, technology, electric, vehicles, healthcare